ROLE OF METHAMPHETAMINE METABOLISM IN THE DEVELOPMENT OF CNS TOLERANCE TO THE DRUG

被引:0
|
作者
ALBURGES, ME
HANSON, GR
GIBB, JW
机构
来源
INVESTIGACION CLINICA | 1990年 / 31卷 / 04期
关键词
METHAMPHETAMINE (METH); AMPHETAMINE (AMP); TOLERANCE; METABOLISM;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have previously observed that pretreatment with increasing doses of methamphetamine (METH) attenuates the effects of METH on the dopaminergic and serotonergic systems as compared with the ones observed in nonpretreated controls. In order to understand the mechanism of this tolerance, untreated rats (naive) and rats pretreated with METH (daily doses of 2.5, 5.0, 7.5, and 10 mg/kg, s.c., at 6h intervals with a 24h drug-free period between each dose) were challenged with the administration of 5 doses of METH (15 mg/kg, s.c., at 6h intervals). The metabolism of METH in brain, liver, and blood was studied by measuring the concentration of METH and its metabolites 2, 4, 6, 8 and 10h after the last dose by gas chromatography/mass spectrometry techniques.
引用
收藏
页码:165 / 176
页数:12
相关论文
共 50 条
  • [31] Vaccine development against methamphetamine drug addiction
    Hossain, Md Kamal
    Hassanzadeganroudsari, Majid
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    EXPERT REVIEW OF VACCINES, 2020, 19 (12) : 1105 - 1114
  • [32] CNS Drug Development - Lost in Translation?
    Talevi, A.
    Bellera, C. L.
    Di Ianni, M.
    Gantner, M.
    Bruno-Blanch, L. E.
    Castro, E. A.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (10) : 959 - 970
  • [33] Phosphodiesterases in the CNS: targets for drug development
    Frank S. Menniti
    W. Stephen Faraci
    Christopher J. Schmidt
    Nature Reviews Drug Discovery, 2006, 5 : 660 - 670
  • [34] Phosphodiesterases in the CNS: targets for drug development
    Menniti, Frank S.
    Faraci, W. Stephen
    Schmidt, Christopher J.
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (08) : 660 - 670
  • [35] Imaging Biomarkers in CNS Drug Development
    Tauscher, J.
    Schwarz, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 34 - 35
  • [36] The utility of biomarkers in CNS drug development
    Palmer, Alan M.
    DRUG DISCOVERY TODAY, 2014, 19 (03) : 201 - 203
  • [37] The role of flavin-containing monooxygenases in drug metabolism and development
    Cashman, JR
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (04) : 486 - 493
  • [38] METABOLISM OF HISTAMINE AND ITS ROLE IN THE CNS ACTIVITY
    MOKHORT, NA
    RADCHENKO, IV
    UKRAINSKII BIOKHIMICHESKII ZHURNAL, 1989, 61 (02): : 3 - 13
  • [39] INHIBITION OF HEPATIC DRUG METABOLISM BY AMPHETAMINE, METHAMPHETAMINE, HYDROXYAMPHETAMINE, AND CHLORAMPHETAMINE
    LOUISFER.R
    PURI, S
    KOWAL, F
    FULLER, G
    LAL, H
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1970, 17 (01) : 287 - &
  • [40] ROLE OF DRUG-METABOLISM IN DRUG RESEARCH AND DEVELOPMENT - FACTORS AFFECTING METABOLISM OF DRUGS AND THEIR PHARMACOLOGICAL AND TOXICOLOGICAL ACTIVITY
    STRIPP, B
    GILLETTE, JR
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (10) : 1682 - &